LYRA - Lyra Therapeutics Forvard narx/daromad multiplikatori

Lyra Therapeutics Inc (LYRA) kompaniyasining korporativ logotipi

Yakuniy sinovlarning muvaffaqiyatsizligi va yagona platformaga bog'liqlik bilan bog'liq xatarlar fonida, GURU.Markets dagi kunlik grafik Lyra Therapeutics, Inc. (LYRA) kompaniyasining forward P/S dinamikasini aks ettiradi, bunda 1.40 metriki parametr holatini belgilaydi. ENT innovatori sifatidagi obro'si shifokorlarning ishonchini mustahkamlasa-da, sinusit bilan bog'liq muvaffaqiyatsizliklardan keyingi joriy portfelni qayta muvozanatlash biznesni xarajatlarni optimallashtirishga va yangi nishalarni izlashga majbur qilmoqda.

LYRA lyratherapeutics.com: Sotuvga nisbatan forvard narx 04.07.2022 - 28.03.2026 oraligʻida

Lyra Therapeutics (LYRA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning umumiy tahlili:Lyra Therapeutics, Inc LYRA
lyratherapeutics.com tomonidan chiqariladigan mahsulotlar

Oldingi P/S ko'rsatkichi biznesning bozor qiymatini kutilayotgan savdo hajmi bilan nisbatda aks ettiradi va bu potentsial o'sish uchun to'langan premiumni baholash imkonini beradi. Lyra Therapeutics, Inc. (LYRA) kompaniyasining prognoz qilingan P/S ko'rsatkichini tahlil qilish orqali investor joriy bozor kapitalizatsiyasini LYR-210 tizimlarining tijoratlashtirilishidan kutilayotgan daromadlar bilan solishtiradi, bu esa kompaniya qiymati surunkali rinosinuzitni davolashdagi kelajakdagi muvaffaqiyatlarga asoslangan biotexnologiya sektori uchun juda muhimdir.

Muhim raqobatchilar

Forvard P/S multiplikatori HLN (Haleon PLC)|Forvard P/S multiplikatori Kenvue Corp KVUE|Verona Pharma PLC - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati jyongbio.com|LGND: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati AMRX|Narxning prognoz qilingan daromadga nisbati Perrigo Company|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alvotech ALVO|Forvard P/S multiplikatori LQDA|GLPG: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori ANIP (ANI Pharmaceuticals, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati MannKind Corp (MNKD)|AMPH: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati TBPH|AQST (Aquestive Corp) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori scPharmaceuticals Inc. (SCPH)|Forvard narx/daromad multiplikatori TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati SXT Pharmaceuticals SXTC|Sotuvga nisbatan forvard narx EPRX|BHST - Narxning prognoz qilingan daromadga nisbati|eXoZymes (EXOZ) - Forvard narx/daromad multiplikatori|ORMP: Forvard P/S multiplikatori|ENTX: Narxning kutilayotgan daromadga nisbati|HYFT (ipatherapeutics.com) - Forvard P/S multiplikatori|Forvard P/S multiplikatori ABVC BioPharma|Narxning prognoz qilingan daromadga nisbati Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori FGEN (fibrogen.com)|Telomir Pharmaceuticals (TELO) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|RANI - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synergy CHC SNYR|RLYB: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Lexaria (LEXX)|Narxning prognoz qilingan daromadga nisbati Pulmatrix|Kapitalizatsiyaning prognoz qilingan daromadga nisbati PTHL (ftzy.com.cn)|Forvard P/S multiplikatori APM|Forvard narx/daromad multiplikatori Impact BioMedical Inc IBO|Narxning prognoz qilingan daromadga nisbati tnfpharma.com TNFA|Sotuvga nisbatan forvard narx YCBD|PainReform Ltd - Forvard P/S multiplikatori|Altamira Therapeutics Ltd (CYTO) - Forvard narx/daromad multiplikatori|lipella.com (LIPO) - Narxning prognoz qilingan daromadga nisbati|OptiNose (OPTN) - Forvard P/S multiplikatori|PIRS (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|PROC: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Petros Pharmaceuticals, Inc. (PTPI)|Forvard P/S multiplikatori Qilian International Corp (QLI)|ACELYRIN, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori tffpharma.com TFFP